RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK - Get Free Report)'s stock price rose 3.6% during mid-day trading on Tuesday . The company traded as high as €14.50 ($14.95) and last traded at €14.40 ($14.85). Approximately 4,653 shares were traded during trading, a decline of 89% from the average daily volume of 43,281 shares. The stock had previously closed at €13.90 ($14.33).
RHÖN-KLINIKUM Aktiengesellschaft Stock Up 3.6 %
The company has a debt-to-equity ratio of 11.59, a quick ratio of 2.12 and a current ratio of 2.34. The business's 50 day moving average is €13.16 and its 200-day moving average is €12.49. The stock has a market cap of $963.94 million, a price-to-earnings ratio of 20.57, a PEG ratio of 26.77 and a beta of -0.13.
About RHÖN-KLINIKUM Aktiengesellschaft
(
Get Free Report)
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider RHÖN-KLINIKUM Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RHÖN-KLINIKUM Aktiengesellschaft wasn't on the list.
While RHÖN-KLINIKUM Aktiengesellschaft currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
